Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Akinori Minato
Observed names:
A. Minato,
AKINORI MINATO,
Akinori MINATO
Institution:
University of Occupational and Environmental Health Japan
Observed institution:
University of Occupational and Environmental Health Japan
ORCID:
0000-0001-6303-1128
Observed ORCID:
0000-0001-6303-1128
OpenAlex ID:
A5082566636
Reconsideration on Clinical Benefit of Pelvic Lymph Node Dissection during Radical Prostatectomy for Clinically Localized Prostate Cancer
2019
·
Naohiro Fujimoto
, Masaki Shiota
, et al.
·
Urologia Internationalis
·
59
Squamous Differentiation Predicts Poor Response to Cisplatin-Based Chemotherapy and Unfavorable Prognosis in Urothelial Carcinoma of the Urinary Bladder
2017
·
Akinori Minato
, Naohiro Fujimoto
, et al.
·
Clinical Genitourinary Cancer
·
58
Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder
2018
·
Akinori Minato
, Hirotsugu Noguchi
, et al.
·
Cancer Control
·
47
Efficacy and Tolerability of Enfortumab Vedotin for Metastatic Urothelial Carcinoma: Early Experience in the Real World
2023
·
AKINORI MINATO
, RIEKO KIMURO
, et al.
·
Anticancer Research
·
36
PDF
The Association of Clinical Outcomes with Posttreatment Changes in the Relative Eosinophil Counts and Neutrophil-to-Eosinophil Ratio in Patients with Advanced Urothelial Carcinoma Treated with Pembrolizumab
2021
·
Nobuki Furubayashi
, Akinori Minato
, et al.
·
Cancer Management and Research
·
25
PDF
Impact of the Use of Proton Pump Inhibitors on Pembrolizumab Effectiveness for Advanced Urothelial Carcinoma
2022
·
IKKO TOMISAKI
, MIRII HARADA
, et al.
·
Anticancer Research
·
23
Efficacy of Pembrolizumab in Patients With Variant Urothelial Carcinoma: A Multicenter Retrospective Study
2022
·
Akinori Minato
, Nobuki Furubayashi
, et al.
·
Clinical Genitourinary Cancer
·
22
PDF
Efficacy and Tolerability of Bacillus Calmette-Guérin Therapy as the First-Line Therapy for Upper Urinary Tract Carcinoma In Situ
2018
·
Ikko Tomisaki
, Tatsuhiko Kubo
, et al.
·
Cancer Investigation
·
22
Prognostic Impact of Histologic Subtype and Divergent Differentiation in Patients with Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multicenter Retrospective Study
2024
·
Akinori Minato
, Nobuki Furubayashi
, et al.
·
Current Oncology
·
21
PDF
Gene Polymorphism-related Individual and Interracial Differences in the Outcomes of Androgen Deprivation Therapy for Prostate Cancer
2017
·
Naohiro Fujimoto
, Masaki Shiota
, et al.
·
Clinical Genitourinary Cancer
·
21
Treatment Strategies for Metastatic Castration-Sensitive Prostate Cancer: From “All-Comers” to “Personalized” Approach
2021
·
Kenichi Harada
, Masaki Shiota
, et al.
·
OncoTargets and Therapy
·
20
PDF
Clinical Outcomes of Enfortumab Vedotin in Advanced Urothelial Carcinoma With Prior Avelumab Versus Pembrolizumab Therapy
2024
·
AKINORI MINATO
, NOBUKI FURUBAYASHI
, et al.
·
Anticancer Research
·
18
Impact of C-reactive Protein Flare Response in Patients With Advanced Urothelial Carcinoma Who Received Pembrolizumab
2021
·
IKKO TOMISAKI
, MIRII HARADA
, et al.
·
In Vivo
·
17
PDF
Reduced Expression Level of GPX2 in T1 Bladder Cancer and its Role in Early-phase Invasion of Bladder Cancer
2021
·
AKINORI MINATO
, HIROTSUGU NOGUCHI
, et al.
·
In Vivo
·
16
PDF
Cutaneous and Renal Toxicities of Enfortumab Vedotin for Advanced Urothelial Carcinoma: The UROKYU Study
2024
·
NOBUKI FURUBAYASHI
, AKINORI MINATO
, et al.
·
Anticancer Research
·
15
Premature Mortality Due to Malignancies of the Kidney and Bladder in Japan, 1980–2010
2018
·
Truong-Minh Pham
, Tatsuhiko Kubo
, et al.
·
Journal of Epidemiology
·
15
PDF
Second-Line Systemic Therapy for Highly Aggressive Neuroendocrine Prostate Cancer
2023
·
NAOHIRO FUJIMOTO
, YUTO TSUBONUMA
, et al.
·
Anticancer Research
·
14
PDF
Receptor for Hyaluronic Acid-mediated Motility (RHAMM) Is Associated With Prostate Cancer Migration and Poor Prognosis
2023
·
AKINORI MINATO
, YUZAN KUDO
, et al.
·
Cancer Genomics & Proteomics
·
14
PDF
Association Between Immune-Related Adverse Events and Efficacy and Changes in the Relative Eosinophil Count Among Patients with Advanced Urothelial Carcinoma Treated by Pembrolizumab
2022
·
Nobuki Furubayashi
, Akinori Minato
, et al.
·
Cancer Management and Research
·
14
PDF
Efficacy of Platinum-based Chemotherapy in Patients With Metastatic Urothelial Carcinoma With Variant Histology
2024
·
AKINORI MINATO
, KAZUKI MUROOKA
, et al.
·
In Vivo
·
13
PDF
Evaluation of the Extent of Variant Histology in Urothelial Carcinoma as a Predictive Marker of Clinical Outcomes After Radical Cystectomy
2021
·
AKINORI MINATO
, HIROTSUGU NOGUCHI
, et al.
·
Cancer Diagnosis & Prognosis
·
13
Organ-Specific Tumor Response to Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study
2024
·
Akinori Minato
, Nobuki Furubayashi
, et al.
·
Clinical Genitourinary Cancer
·
12
PDF
Efficacy of estramustine phosphate according to risk classification of castration-resistant prostate cancer
2012
·
Akinori Minato
, Naohiro Fujimoto
, et al.
·
Medical Oncology
·
10
Combination therapy with paclitaxel and gemcitabine after platinum‐based chemotherapy in patients with advanced urothelial cancer
2021
·
Mirii Harada
, Ikko Tomisaki
, et al.
·
International Journal of Urology
·
9
Three-month Prostate-specific Antigen Level After Androgen Deprivation Therapy Predicts Survival in Patients With Metastatic Castration-sensitive Prostate Cancer
2021
·
NAOHIRO FUJIMOTO
, MASAKI SHIOTA
, et al.
·
In Vivo
·
9
PDF
Show more works
View as search
Works count:
75
Citation count:
659
H-index:
15
I10-index:
23
Year
Topic
Type